324 related articles for article (PubMed ID: 30760220)
1. Cognitive screening in treatment-naïve HIV-infected individuals in Hong Kong - a single center study.
Chan FCC; Chan P; Chan I; Chan A; Tang THC; Lam W; Fong WC; Lee MP; Li P; Chan GHF
BMC Infect Dis; 2019 Feb; 19(1):156. PubMed ID: 30760220
[TBL] [Abstract][Full Text] [Related]
2. The Montreal Cognitive Assessment-Basic (MoCA-B) is not a reliable screening tool for cognitive decline in HIV patients receiving combination antiretroviral therapy in rural South Africa.
Hakkers CS; Beunders AJM; Ensing MHM; Barth RE; Boelema S; Devillé WLJ; Tempelman HA; Coutinho RA; Hoepelman AIM; Arends JE; van Zandvoort MJE
Int J Infect Dis; 2018 Feb; 67():36-40. PubMed ID: 29183843
[TBL] [Abstract][Full Text] [Related]
3. Screening for HIV-associated neurocognitive disorders in perinatally infected adolescents: youth-International HIV Dementia Scale validation.
Phillips NJ; Thomas KGF; Myer L; Sacktor N; Zar HJ; Stein DJ; Hoare J
AIDS; 2019 Apr; 33(5):815-824. PubMed ID: 30649059
[TBL] [Abstract][Full Text] [Related]
4. Psychometric utility of the international HIV dementia scale and Montreal Cognitive Assessment in HIV-associated asymptomatic neurocognitive impairment.
Aita SL; Kaewpoowat Q; Yasri S; Rerkasem A; Rerkasem K; Choovuthayakorn J; Ausayakhun S; Robertson K; Roth RM; Robbins NM
J Neurovirol; 2021 Aug; 27(4):568-578. PubMed ID: 34185242
[TBL] [Abstract][Full Text] [Related]
5. Comparison of two screening tests for HIV-Associated Neurocognitive Disorder suspected Japanese patients with respect to cART usage.
Kami-Onaga K; Tateyama M; Kinjo T; Parrott G; Tominaga D; Takahashi-Nakazato A; Nakamura H; Tasato D; Miyagi K; Maeda S; Arae H; Uehara H; Miyagi K; Haranaga S; Fujita J
PLoS One; 2018; 13(6):e0199106. PubMed ID: 29902251
[TBL] [Abstract][Full Text] [Related]
6. Validation of the International HIV Dementia Scale as a Screening Tool for HIV-Associated Neurocognitive Disorders in a German-Speaking HIV Outpatient Clinic.
Marin-Webb V; Jessen H; Kopp U; Jessen AB; Hahn K
PLoS One; 2016; 11(12):e0168225. PubMed ID: 27992497
[TBL] [Abstract][Full Text] [Related]
7. Limitations of the International HIV Dementia Scale in the current era.
Milanini B; Paul R; Bahemana E; Adamu Y; Kiweewa F; Langat R; Owuoth J; Allen E; Polyak C; Ake J; Valcour V;
AIDS; 2018 Nov; 32(17):2477-2483. PubMed ID: 30134293
[TBL] [Abstract][Full Text] [Related]
8. The Montreal Cognitive Assessment: A Pilot Study of a Brief Screening Tool for Mild and Moderate Cognitive Impairment in HIV-Positive Veterans.
Chartier M; Crouch PC; Tullis V; Catella S; Frawley E; Filanosky C; Carmody T; McQuaid J; Lampiris H; Wong JK
J Int Assoc Provid AIDS Care; 2015; 14(3):197-201. PubMed ID: 25487428
[TBL] [Abstract][Full Text] [Related]
9. Correlates of the HIV-associated neurocognitive disorders among adults living with HIV in Dodoma region, central Tanzania: A cross-sectional study.
Nyundo AA
PLoS One; 2023; 18(5):e0285761. PubMed ID: 37228133
[TBL] [Abstract][Full Text] [Related]
10. Neurocognitive evaluation using the International HIV Dementia Scale (IHDS) and Montreal Cognitive Assessment Test (MoCA) in an HIV-2 population.
Almeida F; Macedo A; Trigo D; Abreu M; Guimarães M; Luís N; Pinho R; Tavares R
HIV Med; 2021 Mar; 22(3):212-217. PubMed ID: 33012065
[TBL] [Abstract][Full Text] [Related]
11. Neuropsychological Assessment of 412 HIV-Infected Individuals in São Paulo, Brazil.
Gascón MRP; Vidal JE; Mazzaro YM; Smid J; Marcusso RMN; Capitão CG; Coutinho EM; Benute GRG; De Lucia MCS; de Oliveira ACP
AIDS Patient Care STDS; 2018 Jan; 32(1):1-8. PubMed ID: 29323557
[TBL] [Abstract][Full Text] [Related]
12. Neurocognitive impairment among HIV-positive individuals in Botswana: a pilot study.
Lawler K; Mosepele M; Ratcliffe S; Seloilwe E; Steele K; Nthobatsang R; Steenhoff A
J Int AIDS Soc; 2010 Apr; 13():15. PubMed ID: 20406460
[TBL] [Abstract][Full Text] [Related]
13. HIV-associated neurocognitive disorder in HIV-infected Koreans: the Korean NeuroAIDS Project.
Ku NS; Lee Y; Ahn JY; Song JE; Kim MH; Kim SB; Jeong SJ; Hong KW; Kim E; Han SH; Song JY; Cheong HJ; Song YG; Kim WJ; Kim JM; Smith DM; Choi JY
HIV Med; 2014 Sep; 15(8):470-7. PubMed ID: 24580888
[TBL] [Abstract][Full Text] [Related]
14. Validity of the International HIV Dementia Scale in South Africa.
Joska JA; Westgarth-Taylor J; Hoare J; Thomas KG; Paul R; Myer L; Stein DJ
AIDS Patient Care STDS; 2011 Feb; 25(2):95-101. PubMed ID: 21214343
[TBL] [Abstract][Full Text] [Related]
15. Screening for neurocognitive impairment in HIV-positive adults aged 50 years and older: Montreal Cognitive Assessment relates to self-reported and clinician-rated everyday functioning.
Fazeli PL; Casaletto KB; Paolillo E; Moore RC; Moore DJ; The Hnrp Group
J Clin Exp Neuropsychol; 2017 Nov; 39(9):842-853. PubMed ID: 28122474
[TBL] [Abstract][Full Text] [Related]
16. A Comparison of Five Brief Screening Tools for HIV-Associated Neurocognitive Disorders in the USA and South Africa.
Joska JA; Witten J; Thomas KG; Robertson C; Casson-Crook M; Roosa H; Creighton J; Lyons J; McArthur J; Sacktor NC
AIDS Behav; 2016 Aug; 20(8):1621-31. PubMed ID: 26860536
[TBL] [Abstract][Full Text] [Related]
17. Utility of the International HIV Dementia Scale for HIV-Associated Neurocognitive Disorder.
Molinaro M; Sacktor N; Nakigozi G; Anok A; Batte J; Kisakye A; Myanja R; Nakasujja N; Robertson KR; Gray RH; Wawer MJ; Saylor D
J Acquir Immune Defic Syndr; 2020 Mar; 83(3):278-283. PubMed ID: 32032278
[TBL] [Abstract][Full Text] [Related]
18. Neurocognitive Disorders in HIV-positive Patients.
Padole PS; Padhiyar RN; Yadav DS; Chavan SA
J Assoc Physicians India; 2023 Jun; 71(6):11-12. PubMed ID: 37355842
[TBL] [Abstract][Full Text] [Related]
19. Depression and diagnosis of neurocognitive impairment in HIV-positive patients.
Pinheiro CA; Souza LD; Motta JV; Kelbert EF; Souza MS; Martins CS; Coelho FM; Pinheiro KA; Pinheiro RT
Braz J Med Biol Res; 2016 Sep; 49(10):e5344. PubMed ID: 27626305
[TBL] [Abstract][Full Text] [Related]
20. Cognitive impairment and neurocognitive profiles among people living with HIV and HIV-negative individuals older over 50 years: a comparison of IHDS, MMSE and MoCA.
Chen P; Xin X; Xiao S; Liu H; Liu X; He N; Ding Y
J Neurovirol; 2024 May; ():. PubMed ID: 38709469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
